Latest filing published 28 Jul 2022 for Repare Therapeutics Inc..
Insider track record
No signal scores available.
Jerel Davis: trading record in brief
Jerel Davis discloses dealings in Repare Therapeutics Inc. to SEC (Form 4). In total, 9 filings cover trades dated from 22 June 2020 to 6 June 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 28 July 2022: a transaction, in Repare Therapeutics Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jerel Davis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9 sharesCommon SharesTSXSEDI:3981725
- 2,842 sharesCommon SharesTSXSEDI:3981724
- 5,277 sharesCommon SharesTSXSEDI:3981722
- 19 sharesCommon SharesTSXSEDI:3981726
- 2,799 sharesCommon SharesTSXSEDI:3981721
- 830 sharesCommon SharesTSXSEDI:3981723
- 6,448 sharesCommon SharesTSXSEDI:3959705
- 2,653 sharesCommon SharesTSXSEDI:3959702
- Common SharesTSXSEDI:3959697
9 of 9 declarations
